Answer
The selected prolonged-release tapentadol product is licensed for severe chronic pain in adults when adequate management requires an opioid.
Sources for this answer
- Tapentadol Krka 100 mg prolonged-release tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.